246 related articles for article (PubMed ID: 11526920)
41. [Hydroxyethylstarches and renal failure: to keep the reason is a necessity].
Godet G; Girard C; Guidet B; Ichai C; Lehot JJ; Leone M; Martin C; Muller L; Orliaguet G; Payen JF; Sztark F
Ann Fr Anesth Reanim; 2013 Sep; 32(9):535-8. PubMed ID: 23972629
[No Abstract] [Full Text] [Related]
42. [HES, dextran and gelatin--indications and tolerance].
Laubenthal H; Sirtl C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
[No Abstract] [Full Text] [Related]
43. Infusion of hydroxyethyl starch-containing fluids.
Aubron C; Bellomo R
Minerva Anestesiol; 2013 Sep; 79(9):1088-92. PubMed ID: 24042155
[TBL] [Abstract][Full Text] [Related]
44. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?
Boldt J
Drug Saf; 2002; 25(12):837-46. PubMed ID: 12241125
[TBL] [Abstract][Full Text] [Related]
45. Data too important to share: do those who control the data control the message?
Doshi P
BMJ; 2016 Mar; 352():i1027. PubMed ID: 26936297
[No Abstract] [Full Text] [Related]
46. Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants.
Bernard C; Alain M; Simone C; Xavier M; Jean-François M
Lancet; 1996 Dec; 348(9041):1595. PubMed ID: 8950915
[No Abstract] [Full Text] [Related]
47. Effects of hydroxyethyl starch in critically ill patients.
Brunkhorst FM; Schortgen F
Br J Anaesth; 2007 Jun; 98(6):842-3; author reply 843-4. PubMed ID: 17519265
[No Abstract] [Full Text] [Related]
48. Why hydroxyethyl starch solutions should NOT be banned from the operating room.
De Hert S; De Baerdemaeker L
Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553
[TBL] [Abstract][Full Text] [Related]
49. EMA confirms that hydroxyethyl starch solutions should not be used in critically ill, sepsis, or burns patients.
Mayor S
BMJ; 2013 Oct; 347():f6197. PubMed ID: 24126958
[No Abstract] [Full Text] [Related]
50. [Risk with strict glucose control and hydroxyethyl starch in severe sepsis. Routine intensive care treatments are now questioned].
Berggren L
Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3516-7. PubMed ID: 19133578
[No Abstract] [Full Text] [Related]
51. [Evaluation of the liberation of urinary necrosis enzymes (NAG-AAP) after administration of plasma expanders: study of dextran 40, hydroxyethyl starch and polymerized gelatin].
Lanza V; Guglielmo L; Sapio M; Sanfilippo A; La Chiusa S
Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1155-61. PubMed ID: 2483317
[TBL] [Abstract][Full Text] [Related]
52. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.
Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N
Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091
[TBL] [Abstract][Full Text] [Related]
53. [Volume replacement and coagulation impairment].
Levi M; De Jonge E
Minerva Anestesiol; 2005 Dec; 71(12 Suppl 1):11-6. PubMed ID: 16434957
[No Abstract] [Full Text] [Related]
54. Changes in Serum Creatinine Concentration and Acute Kidney Injury (AKI) Grade in Dogs Treated with Hydroxyethyl Starch 130/0.4 From 2013 to 2015.
Sigrist NE; Kälin N; Dreyfus A
J Vet Intern Med; 2017 Mar; 31(2):434-441. PubMed ID: 28109131
[TBL] [Abstract][Full Text] [Related]
55. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.
Shaw AD; Kellum JA
Clin J Am Soc Nephrol; 2013 Mar; 8(3):497-503. PubMed ID: 23335037
[TBL] [Abstract][Full Text] [Related]
56. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
[TBL] [Abstract][Full Text] [Related]
57. [Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
Ring J; Seifert J; Struif E; Messmer K; Brendel W
Chir Forum Exp Klin Forsch; 1977 Apr; ():31-5. PubMed ID: 87295
[TBL] [Abstract][Full Text] [Related]
58. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery.
Rioux JP; Lessard M; De Bortoli B; Roy P; Albert M; Verdant C; Madore F; Troyanov S
Crit Care Med; 2009 Apr; 37(4):1293-8. PubMed ID: 19242349
[TBL] [Abstract][Full Text] [Related]
59. Trauma experts urge cautious use of i.v. fluids.
Traynor K
Am J Health Syst Pharm; 2012 Nov; 69(21):1846, 1848. PubMed ID: 23111663
[No Abstract] [Full Text] [Related]
60. Concerns about renal safety of HES 130. Authors' response.
Boussekey N; Leroy O
Crit Care; 2013; 17(4):444. PubMed ID: 25162074
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
